Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Birth Defects Research. Part C, Embryo Today : Reviews
|
September 28, 2005
Muscle function and dysfunction in health and disease
Michael S Huh, Johnathan K Smid, Michael A Rudnicki
European Journal of Human Genetics : EJHG
|
May 12, 2016
The sub-nucleolar localization of PHF6 defines its role in rDNA transcription and early processing events
Matthew A M Todd, Michael S Huh, David J Picketts
Physiology (Bethesda, Md.)
|
April 15, 2009
SCO-ping out the mechanisms underlying the etiology of hydrocephalus
Michael S Huh, Matthew A M Todd, David J Picketts
The Journal of Cell Biology
|
September 15, 2004
Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation
Michael S Huh, Maura H Parker, Anthony Scimè, et al.
Plos One
|
November 3, 2017
Recovery from impaired muscle growth arises from prolonged postnatal accretion of myonuclei in Atrx mutant mice
Michael S Huh, Kevin G Young, Keqin Yan, et al.
Plos Biology
|
January 3, 2020
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity
Courtney A Lovejoy, Kaori Takai, Michael S Huh, et al.
Cell Metabolism
|
November 8, 2005
Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha
Anthony Scimè, Guillaume Grenier, Michael S Huh, et al.
The Journal of Clinical Investigation
|
November 2, 2012
Compromised genomic integrity impedes muscle growth after Atrx inactivation
Michael S Huh, Tina Price O'Dea, Dahmane Ouazia, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2018
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference
Donald Bastin, Amelia S Aitken, Adrian Pelin, et al.
Molecular Therapy Oncolytics
|
December 3, 2016
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
Laura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Birth Defects Research. Part C, Embryo Today : Reviews
|
September 28, 2005
Muscle function and dysfunction in health and disease
Michael S Huh, Johnathan K Smid, Michael A Rudnicki
European Journal of Human Genetics : EJHG
|
May 12, 2016
The sub-nucleolar localization of PHF6 defines its role in rDNA transcription and early processing events
Matthew A M Todd, Michael S Huh, David J Picketts
Physiology (Bethesda, Md.)
|
April 15, 2009
SCO-ping out the mechanisms underlying the etiology of hydrocephalus
Michael S Huh, Matthew A M Todd, David J Picketts
The Journal of Cell Biology
|
September 15, 2004
Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation
Michael S Huh, Maura H Parker, Anthony Scimè, et al.
Plos One
|
November 3, 2017
Recovery from impaired muscle growth arises from prolonged postnatal accretion of myonuclei in Atrx mutant mice
Michael S Huh, Kevin G Young, Keqin Yan, et al.
Plos Biology
|
January 3, 2020
ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity
Courtney A Lovejoy, Kaori Takai, Michael S Huh, et al.
Cell Metabolism
|
November 8, 2005
Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha
Anthony Scimè, Guillaume Grenier, Michael S Huh, et al.
The Journal of Clinical Investigation
|
November 2, 2012
Compromised genomic integrity impedes muscle growth after Atrx inactivation
Michael S Huh, Tina Price O'Dea, Dahmane Ouazia, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2018
Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference
Donald Bastin, Amelia S Aitken, Adrian Pelin, et al.
Molecular Therapy Oncolytics
|
December 3, 2016
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
Laura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, et al.
Page
of 2